牙周炎和前列腺疾病相关性研究现状

doi:10.13591/j.cnki.kqyx.2022.01.017

Abstract

Abstract: Periodontitis is a common oral inflammatory disease. An enormous amount of literature has reported that periodontitis is closely related to systemic diseases, such as cardiovascular disease, type 2 diabetes, premature low-birth weight infants and so on. Periodontitis and prostate diseases have similar risk factors. Age, smoking, obesity and diabetes, as well as inflammatory stimulation, have a significant impact on the disease. This article mainly reviews the research status of the relationship between periodontitis and prostate diseases, common influencing factors, and related biological mechanisms.

Key words: periodontitis, benign prostatic hyperplasia, prostate cancer, prostate-specific antigen, androgen deprivation therapy

CLC Number:

R781.42

CHEN Nianjie, ZHONG Liangjun. Research status of the relationship between periodontitis and prostate diseases[J]. Stomatology, 2022, 42(1): 92-96.

References

[1] Frencken JE, Sharma P, Stenhouse L, et al.Global epidemiology of dental caries and severe periodontitis-a comprehensive review[J]. J Clin Periodontol, 2017, 44 (Suppl 18):S94-S105.
[2] Tonetti MS, Henry G, Kornman KS. Staging and grading of periodontitis: Framework and proposal of a new classification and case definition[J]. J Periodontol, 2018, 89(Suppl 1) :S159-S172.
[3] Freddie, Bray, Jacques, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.[J]. CA Cancer J Clin, 2018, 68(6):394-424.
[4] Siegel RL, Miller KD, Fuchs HE,et al. Cancer statistics, 2021[J]. CA Cancer J Clin, 2021, 71(1):7-33.
[5] Lee SWH, Chan EMC, Lai YK. The global burden of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: A systematic review and meta-analysis[J]. Sci Rep, 2017, 7(1):7984.
[6] Kinane DF, Stathopoulou PG, Papapanou PN. Periodontal diseases[J]. Nat Rev Dis Primers, 2017, 3:17038.
[7] Thurnheer T, Karygianni L, Flury M, et al. Fusobacterium species and subspecies differentially affect the composition and architecture of supra-and subgingival biofilms models[J]. Front Microbiol, 2019, 10: 1716.
[8] Tomás I, Regueira-Iglesias A, López M, et al. Quantification by qPCR of pathobionts in chronic periodontitis: Development of predictive models of disease severity at site-specific level[J]. Front Microbiol, 2017, 8: 1443.
[9] Kassebaum NJ, Bernabé E, Dahiya M, et al. Global burden of severe periodontitis in 1990—2010: A systematic review and meta-regression[J]. J Dent Res, 2014, 93(11):1045-1053.
[10] Slots J. Life-threatening pathogens in severe/progressive periodontitis: Focal infection risk, future periodontal practice, role of the Periodontology 2000[J]. Periodontol 2000, 2020, 84(1):215-216.
[11] Kholy KE, Genco RJ, Dyke TEV. Oral infections and cardiovascular disease[J]. Trends Endocrinol Metab, 2015, 26(6):315-321.
[12] Choi SE, Sima C, Pandya A. Impact of treating oral disease on preventing vascular diseases: A model-based cost-effectiveness analysis of periodontal treatment among patients with type 2 diabetes[J]. Diabetes Care, 2020, 43(3):563-571.
[13] Ye C, Xia Z, Tang J, et al. Unculturable and culturable periodontal-related bacteria are associated with periodontal inflammation during pregnancy and with preterm low birth weight delivery[J]. Sci Rep, 2020, 10(1):15807.
[14] Passos-Soares JS, Vianna MIP, Gomes-Filho IS, et al. Association between osteoporosis treatment and severe periodontitis in postmenopausal women[J]. Menopause, 2017, 24(7):789-795.
[15] Corrêa JD, Fernandes GR, Calderaro DC, et al. Oral microbial dysbiosis linked to worsened periodontal condition in rheumatoid arthritis patients[J]. Sci Rep, 2019, 9(1):8379.
[16] Botelho J, Patrícia L, Proena LFA, et al. Relationship between blood and standard biochemistry levels with periodontitis in Parkinson's disease patients: data from the NHANES 2011-2012[J]. J Pers Med, 2020, 10(3):69.
[17] Matsushita K, Yamada-Furukawa M, Kurosawa M, et al. Periodontal disease and periodontal disease-related bacteria involved in the pathogenesis of Alzheimer's disease[J]. J Inflamm Res, 2020, 13:275-283.
[18] Michaud DS, Lu J, Peacock-Villada AY, et al. Periodontal disease assessed using clinical dental measurements and cancer risk in the ARIC study[J]. J Natl Cancer Inst, 2018, 110(8):843-854.
[19] Maisonneuve P, Amar S, Lowenfels AB. Periodontal disease, edentulism, and pancreatic cancer: A meta-analysis[J]. Ann Oncol, 2017, 28(5):985-995.
[20] Gaudreau PO, Stagg J, Soulières D, et al. The present and future of biomarkers in prostate cancer: Proteomics, genomics, and immunology advancements[J]. Biomark Cancer, 2016, 8(suppl 2):15-33.
[21] Xie T, Dong B, Yan Y, et al. Association between MMP-2 expression and prostate cancer: A meta-analysis[J]. Biomed Rep, 2016, 4(2):241-245.
[22] Ugge H, Downer MK, Carlsson J, et al. Circulating inflammation markers and prostate cancer[J]. Prostate, 2019, 79(11):1338-1346.
[23] Gillard M, Javier R, Ji Y, et al. Elevation of stromal-derived mediators of inflammation promote prostate cancer progression in African-American men[J]. Cancer Res, 2018, 78(21):6134-6145.
[24] Dennis LK, Dawson DV. Meta-analysis of measures of sexual activity and prostate cancer[J]. Epidemiology, 2002, 13(1):72-79.
[25] Kim DH, Jeong SN, Lee JH. Chronic periodontal disease increases risk for prostate cancer in elderly individuals in south Korea: A retrospective nationwide population-based cohort study[J]. J Cancer, 2020, 11(16):4716-4723.
[26] Michaud DS, Lu J, Peacock-Villada AY, et al. Periodontal disease assessed using clinical dental measurements and cancer risk in the ARIC study[J]. J Natl Cancer Inst, 2018, 110(8):843-854.
[27] Dizdar O, Hayran M, Guven DC, et al. Increased cancer risk in patients with periodontitis[J]. Curr Med Res Opin, 2017, 33(12):2195-2200.
[28] Hiraki A, Matsuo K, Suzuki T, et al. Teeth loss and risk of cancer at 14 common sites in Japanese[J]. Cancer Epidemiol Biomarkers Prev, 2008, 17(5):1222-1227.
[29] Vuichoud C, Loughlin KR. Benign prostatic hyperplasia: epidemiology, economics and evaluation.[J]. Can J Urol, 2015, 22(5S1):1-6.
[30] Ramseier CA, Woelber JP, Kitzmann J, et al. Impact of risk factor control interventions for smoking cessation and promotion of healthy lifestyles in patients with periodontitis: A systematic review[J]. J Clin Periodontol, 2020, 47(Suppl 22):90-106.
[31] Palapattu GS, Sutcliffe S, Bastian PJ, et al. Prostate carcinogenesis and inflammation: Emerging insights[J]. Carcinogenesis, 2005, 26(7):1170-1181.
[32] Boland MR, Hripcsak G, Albers DJ, et al. Discovering medical conditions associated with periodontitis using linked electronic health records[J]. J Clin Periodontol, 2013, 40(5):474-482.
[33] Estemalik J, Demko C, Bissada NF, et al. Simultaneous detection of oral pathogens in subgingival plaque and prostatic fluid of men with periodontal and prostatic diseases.[J]. J Periodontol, 2017, 88(9):823-829.
[34] Wu L, Li BH, Wang YY, et al. Periodontal disease and risk of benign prostate hyperplasia: A cross-sectional study[J]. Mil Med Res, 2019, 6(1):34.
[35] Moradi A, Srinivasan S, Clements J, et al. Beyond the biomarker role: Prostate-specific antigen (PSA) in the prostate cancer microenvironment[J]. Cancer Metastasis Rev, 2019, 38(3):333-346.
[36] Joshi N, Bissada NF, Bodner D, et al. Association between periodontal disease and prostate-specific antigen levels in chronic prostatitis patients[J]. J Periodontol, 2010, 81(6):864-869.
[37] Boyapati R, Chintalapani S, Ramisetti A, et al. Evaluation of serum leptin and adiponectin in obese individuals with chronic periodontitis[J]. Contemp Clin Dent, 2018, 9(suppl 2):S210-S214.
[38] Bissada NANF. Periodontal treatment improves prostate symptoms and lowers serum PSA in men with high PSA and chronic periodontitis[J]. Dentistry, 2015, 5(3):284.
[39] Kruck S, Hennenlotter J, Amend B, et al. Chronic periodontitis does not impact serum levels of prostate-specific antigen[J]. Anticancer Res, 2017, 37(6):3163-3167.
[40] Huang YH, Michaud DS, Lu JY, et al. The association between clinically determined periodontal disease and prostate-specific antigen concentration in men without prostate cancer: The 2009—2010 National Health and Nutrition Examination Survey[J]. Cancer Causes Control, 2019, 30(12):1293-1300.
[41] Chang JH, Wang LF, Lu SL, et al. NF-κB enhances androgen receptor expression through 5'-UTR binding in gingival cells[J]. J Dent Res, 2016, 94(10):1439-1445.
[42] de Paiva Gonçalves V, Ortega AAC, Steffens JP, et al. Long-term testosterone depletion attenuates inflammatory bone resorption in the ligature-induced periodontal disease model[J]. J Periodontol, 2018, 89(4):466-475.
[43] Sharifi N, Gulley JL, Dahut WL. Androgen deprivation therapy for prostate cancer[J]. JAMA, 2005,294(2):238-244.
[44] Alibhai SMH, Duong-Hua M, Sutradhar R, et al. Impact of androgen deprivation therapy on cardiovascular disease and diabetes[J]. J Clin Oncol, 2009, 27(21):3452-3458.
[45] Nead KT, Gaskin G, Chester C, et al. Influence of age on androgen deprivation therapy-associated Alzheimer's disease[J]. Rep, 2016, 6(1):35695.
[46] Famili P, Cauley JA, Greenspan SL. The effect of androgen deprivation therapy on periodontal disease in men with prostate cancer[J]. J Urol, 2007, 177(3):921-924.
[47] Park KJ, Choi SH, Lee JS, et al. Risk stratification of prostate cancer according to PI-RADS^® version 2 categories: Meta-analysis for prospective studies[J]. J Urol, 2020, 204(6):1141-1149.
[48] Pernar CH, Ebot EM, Wilson KM, et al. The epidemiology of prostate cancer[J]. Cold Spring Harb Perspect Med, 2018,8(12):a030361.
[49] Porcaro AB, Tafuri A, Novella G, et al. Inverse association of prostatic chronic inflammation among prostate cancer tumor grade groups: Retrospective study of 738 consecutive cases elected to a first random biopsy set[J]. Urol Int, 2018, 100(4):456-462.
[50] Coulthwaite L, Verran J. Potential pathogenic aspects of denture plaque[J]. Br J Biomed Sci, 2007, 64(4):180-189.
[51] De Nunzio C, Presicce F, Tubaro A. Inflammatory mediators in the development and progression of benign prostatic hyperplasia[J]. Nat Rev Urol, 2016, 13(10):613-626.
[52] da Silva APB, Alluri LSC, Bissada NF, et al. Association between oral pathogens and prostate cancer: Building the relationship[J]. Am J Clin Exp Urol, 2019, 7(1):1-10.
[53] Porter CM, Shrestha E, Peiffer LB, et al. The microbiome in prostate inflammation and prostate cancer[J]. Prostate Cancer Prostatic Dis, 2018, 21(3):345-354.
[54] Noack B, Genco RJ, Trevisan M, et al. Periodontal infections contribute to elevated systemic C-reactive protein level[J]. J Periodontol, 2001, 72(9):1221-1227.
[55] Nishimura F, Iwamoto Y, Mineshiba J, et al. Periodontal disease and diabetes mellitus: The role of tumor necrosis factor-alpha in a 2-way relationship[J]. J Periodontol, 2003, 74(1):97-102.
[56] Alexander RB, Ponniah S, Hasday J, et al. Elevated levels of proinflammatory cytokines in the semen of patients with chronic prostatitis/chronic pelvic pain syndrome[J]. Urology, 1998, 52(5):744-749.
[57] Kellesarian SV, Kellesarian TV, Ros Malignaggi V, et al. Association between periodontal disease and erectile dysfunction: A systematic review[J]. Am J Men's Heal, 2018, 12(2):338-346.
[58] Bi M, Yu H, Huang B, et al. Long non-coding RNA PCAT-1 over-expression promotes proliferation and metastasis in gastric cancer cells through regulating CDKN1A[J]. Gene, 2017, 626: 337-343.
[59] Jia B, Qiu X, Chen J, et al. A feed-forward regulatory network lncPCAT1/miR-106a-5p/E2F5 regulates the osteogenic differentiation of periodontal ligament stem cells[J]. J Cell Physiol, 2019, 234(11):19523-19538.

Research status of the relationship between periodontitis and prostate diseases

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	ZHOU Huirong, LIN Xiaoping. Research advances in correlation between chronic periodontitis and prostatic diseases [J]. Stomatology, 2023, 43(3): 273-277.
[2]	XIE Yongmei, GE Huabing, FENG Jie, LIU Qi, ZHANG Ning, ZHONG Xiaoli. A short-term efficacy evaluation of biological antibacterial peptides in the adjuvant therapy of stageⅢ periodontitis [J]. Stomatology, 2023, 43(3): 237-241.
[3]	WANG Dexu, LUO Xiaojie, CHEN Xiaotao. Research progress of research on the effect of quorum-sensing system on periodontal pathogens [J]. Stomatology, 2023, 43(3): 267-272.
[4]	LEI Gang, WEI Xin, YAN Ming, ZHOU Lili, YU Jinhua, WANG Juan, WU Jintao. Clinical effects of iRoot BP plus and mineral trioxide aggregate in treatment of apical periodontitis with open apical permanent teeth [J]. Stomatology, 2023, 43(2): 118-124.
[5]	ZHANG Chaoying, GONG Jiaxing, YU Mengfei, QIAN Ying, ZHU Ziyu, LU Kejie, WANG Huiming. Application progress of alveolar ridge preservation in patients with tooth extracted due to periodontitis [J]. Stomatology, 2023, 43(2): 159-165.
[6]	SUN Yuezhang,WANG Qi. Morphological and immune characteristics of periodontal tissues under hyperglycemia [J]. Stomatology, 2023, 43(2): 153-158.
[7]	DAI Anna,DING Peihui. Periodontal therapy for stage Ⅳ grade C generalized periodontitis: A case report of 7-year follow-up [J]. Stomatology, 2023, 43(2): 145-152.
[8]	GENG Ying, MA Lu, FENG Zehua, WANG Xiaoqian, XU Yan, LI Lu. Evaluation of periodontal minimally invasive non-surgical therapy for the treatment of upper anterior teeth of patients with thin gingival phenotype [J]. Stomatology, 2022, 42(9): 807-812.
[9]	LIU Yuqing, GONG Yao, ZHAO Sufeng, DAI Li. Regulation effect of miR-155 on osteogenic differentiation of periodontal ligament stem cells in inflammatory microenvironment [J]. Stomatology, 2022, 42(9): 790-795.
[10]	ZHANG Shuting, WU Yaxing, LIU Cuicui, LI Chenchen, ZHANG Jing. Research progress of exosomes in osteogenic differentiation of bone marrow mesenchymal stem cells and in periodontal regeneration [J]. Stomatology, 2022, 42(8): 741-744.
[11]	LU Lijie, MIAO Lei, DENG Yu, PAN Yaping. Restoration of oral function by dental implantation combined with free gingival graft in a patient with distal-extension absence and periodontitis:A case report [J]. Stomatology, 2022, 42(8): 727-731.
[12]	YANG Ruoqu, HUO Pengcheng, HU Congjiao, SHI Mingyan, LUO Lijun. Microbiological and clinical effects of adjunctive azithromycin on non-surgical periodontal therapy of patients with stage Ⅲ/Ⅳ periodontitis [J]. Stomatology, 2022, 42(7): 609-616.
[13]	YANG Zizhen, REN Xiuyun. Application of glycine air polishing in plaque control [J]. Stomatology, 2022, 42(7): 641-644.
[14]	DING Xu, LI Xin, LIU Xinchan, HOU Yubo, WU Zhou, YU Weixian. Role of mammalian target of rapamycin in renal injury associated with periodontitis in rats [J]. Stomatology, 2022, 42(5): 420-424.
[15]	SHEN Yue, ZHANG Yuan, CHEN Nianjie, HUANG Xinzhao, ZHONG Liangjun. Clinical and microbiological evaluation of Nd: YAP laser for adjuvant treatment of periodontitis [J]. Stomatology, 2022, 42(5): 446-450.